Literature DB >> 11313284

Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1.

J M Moulds1, P A Zimmerman, O K Doumbo, L Kassambara, I Sagara, D A Diallo, J P Atkinson, M Krych-Goldberg, R E Hauhart, D E Hourcade, D T McNamara, D J Birmingham, J A Rowe, J J Moulds, L H Miller.   

Abstract

Complement receptor 1 (CR1) has been implicated in rosetting of uninfected red blood cells to Plasmodium falciparum-infected cells, and rosette formation is associated with severe malaria. The Knops blood group (KN) is located on CR1 and some of these antigens, ie, McCoy (McC) and Swain-Langley (Sl(a)), show marked frequency differences between Caucasians and Africans. Thus, defining the molecular basis of these antigens may provide new insight into the mechanisms of P falciparum malaria. Monoclonal antibody epitope mapping and serologic inhibition studies using CR1 deletion constructs localized McC and Sl(a) to long homologous repeat D of CR1. Direct DNA sequencing of selected donors identified several single nucleotide polymorphisms in exon 29 coding for complement control protein modules 24 and 25. Two of these appeared to be blood group specific: McC associated with K1590E and Sl(a) with R1601G. These associations were confirmed by inhibition studies using allele-specific mutants. A sequence-specific oligonucleotide probe hybridization assay was developed to genotype several African populations and perform family inheritance studies. Concordance between the 1590 mutation and McC was 94%; that between Sl(a) and 1601 was 88%. All but 2 samples exhibiting discrepancies between the genotype and phenotype were found to be due to low red cell CR1 copy numbers, low or absent expression of some alleles, or heterozygosity combined with low normal levels of CR1. These data further explain the variability observed in previous serologic studies of CR1 and show that DNA and protein-based genetic studies will be needed to clarify the role of the KN antigens in malaria.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313284     DOI: 10.1182/blood.v97.9.2879

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Extensive genomic and functional polymorphism of the complement control proteins.

Authors:  Craig A McLure; Joseph F Williamson; Louise A Smyth; Suraksha Agrawal; Susan Lester; John A Millman; Peter J Keating; Brent J Stewart; Roger L Dawkins
Journal:  Immunogenetics       Date:  2005-11-11       Impact factor: 2.846

Review 2.  Development of complement therapeutics for inhibition of immune-mediated red cell destruction.

Authors:  Karina Yazdanbakhsh
Journal:  Transfusion       Date:  2005-08       Impact factor: 3.157

3.  Characterization of chromosomally assigned replication-competent gamma porcine endogenous retroviruses derived from a large white pig and expression in human cells.

Authors:  Marcus Niebert; Claire Rogel-Gaillard; Patrick Chardon; Ralf R Tönjes
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  A complement receptor-1 polymorphism with high frequency in malaria endemic regions of Asia but not Africa.

Authors:  B N Thomas; B Donvito; I Cockburn; T Fandeur; J A Rowe; J H M Cohen; J M Moulds
Journal:  Genes Immun       Date:  2005-02       Impact factor: 2.676

5.  Severity of malaria in relation to a complement receptor 1 polymorphism: a case-control study.

Authors:  Rebecca Tettey; Patrick Ayeh-Kumi; Prudence Tettey; George O Adjei; Richard H Asmah; Daniel Dodoo
Journal:  Pathog Glob Health       Date:  2015-04-27       Impact factor: 2.894

6.  CR1 Knops blood group alleles are not associated with severe malaria in the Gambia.

Authors:  P A Zimmerman; J Fitness; J M Moulds; D T McNamara; L J Kasehagen; J Alexandra Rowe; A V S Hill
Journal:  Genes Immun       Date:  2003-07       Impact factor: 2.676

7.  Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting.

Authors:  J Alexandra Rowe; Ian G Handel; Mahamadou A Thera; Anne-Marie Deans; Kirsten E Lyke; Abdoulaye Koné; Dapa A Diallo; Ahmed Raza; Oscar Kai; Kevin Marsh; Christopher V Plowe; Ogobara K Doumbo; Joann M Moulds
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-24       Impact factor: 11.205

8.  Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients.

Authors:  S Sadallah; C Hess; M Trendelenburg; C Vedeler; M Lopez-Trascasa; J A Schifferli
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

Review 9.  Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention.

Authors:  J Alexandra Rowe; D Herbert Opi; Thomas N Williams
Journal:  Curr Opin Hematol       Date:  2009-11       Impact factor: 3.284

Review 10.  Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications.

Authors:  J Alexandra Rowe; Antoine Claessens; Ruth A Corrigan; Mònica Arman
Journal:  Expert Rev Mol Med       Date:  2009-05-26       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.